Colgate

Feb 04, 2024

Shares of Colgate-Palmolive (NYSE:CL - Get Free Report) have been assigned an average rating of "Moderate Buy" from the eleven brokerages that are covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $85.33.

CL has been the subject of several research analyst reports. Royal Bank of Canada restated a "sector perform" rating and issued a $83.00 price objective on shares of Colgate-Palmolive in a report on Monday, July 31st. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Colgate-Palmolive from $88.00 to $91.00 and gave the company a "buy" rating in a report on Monday, July 31st. StockNews.com upgraded shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a report on Friday, August 25th. Finally, Barclays lifted their target price on shares of Colgate-Palmolive from $77.00 to $81.00 and gave the company an "equal weight" rating in a report on Tuesday, August 1st.

Read Our Latest Stock Analysis on Colgate-Palmolive

CL opened at $73.85 on Thursday. The stock has a market cap of $61.05 billion, a PE ratio of 41.03, a P/E/G ratio of 3.13 and a beta of 0.49. The company has a quick ratio of 0.73, a current ratio of 1.17 and a debt-to-equity ratio of 28.43. Colgate-Palmolive has a 52 week low of $67.84 and a 52 week high of $82.09. The business's fifty day simple moving average is $75.92 and its 200 day simple moving average is $75.87.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, July 28th. The company reported $0.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.75 by $0.02. The company had revenue of $4.82 billion for the quarter, compared to analysts' expectations of $4.70 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 8.02%. Colgate-Palmolive's quarterly revenue was up 7.5% on a year-over-year basis. During the same period last year, the firm earned $0.72 earnings per share. As a group, research analysts expect that Colgate-Palmolive will post 3.17 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, August 15th. Shareholders of record on Friday, July 21st were paid a $0.48 dividend. This represents a $1.92 annualized dividend and a yield of 2.60%. The ex-dividend date was Thursday, July 20th. Colgate-Palmolive's payout ratio is currently 106.67%.

In related news, insider John W. Kooyman sold 21,677 shares of the company's stock in a transaction dated Wednesday, August 2nd. The shares were sold at an average price of $77.69, for a total transaction of $1,684,086.13. Following the transaction, the insider now directly owns 6,384 shares in the company, valued at approximately $495,972.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.34% of the company's stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of CL. Beaumont Financial Advisors LLC raised its holdings in Colgate-Palmolive by 2.7% in the first quarter. Beaumont Financial Advisors LLC now owns 4,842 shares of the company's stock valued at $364,000 after acquiring an additional 127 shares in the last quarter. NorthRock Partners LLC raised its holdings in Colgate-Palmolive by 4.7% in the first quarter. NorthRock Partners LLC now owns 2,824 shares of the company's stock valued at $212,000 after acquiring an additional 128 shares in the last quarter. Rowland & Co. Investment Counsel ADV raised its holdings in Colgate-Palmolive by 3.7% in the first quarter. Rowland & Co. Investment Counsel ADV now owns 3,695 shares of the company's stock valued at $278,000 after acquiring an additional 133 shares in the last quarter. Gladstone Institutional Advisory LLC raised its holdings in Colgate-Palmolive by 2.1% in the first quarter. Gladstone Institutional Advisory LLC now owns 6,329 shares of the company's stock valued at $476,000 after acquiring an additional 133 shares in the last quarter. Finally, Zullo Investment Group Inc. raised its holdings in Colgate-Palmolive by 4.6% in the second quarter. Zullo Investment Group Inc. now owns 3,088 shares of the company's stock valued at $238,000 after acquiring an additional 137 shares in the last quarter. Hedge funds and other institutional investors own 78.36% of the company's stock.

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.